SEARCH

SEARCH BY CITATION

References

  • 1
    Lok ASF, McMohen B. Chronic hepatitis B. HEPATOLOGY 2001; 34: 12251241.
  • 2
    National Institute of Allergy and Infectious Disease. Treating hepatitis B. Updated September 15, 1999. Available at: www.niaid.nih.gov/director/usmed/1997/usmed97e.htm. Accessed July 18, 2004.
  • 3
    Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. HEPATOLOGY 1998; 27: 209212.
  • 4
    Spiegel BMR, Younossi ZM, Hays RD, Revicki D, Robbins S, Kanwal F. The impact of hepatitis C on health related quality of life: a systematic review of the literature. HEPATOLOGY 2005; 41: 790800.
  • 5
    Hays RD, Anderson RT, Revicki D. Assessing reliability and validity of measurement in clinical trials. In: StaquetMJ, HaysRD, FayersPM, eds. Quality of Life Assessment in Clinical Trials: Methods and Practice. Oxford: Oxford University Press, 1998: 169182.
  • 6
    Staquet MJ, Hays RD, Fayers PM. Factor analysis. In: StaquetMJ, HaysRD, FayersPM, eds. Quality of Life Assessment in Clinical Trials: Methods and Practice. Oxford: Oxford University Press, 1998: 191223.
  • 7
    Litwin MS. Scaling and scoring. In: LitwinMS, ed. How to Measure Survey Reliability and Validity. SAGE Publications Inc., 1995: 4752.
  • 8
    Cohen J. Statistical Power Analysis for the Behavioral Sciences. London: Academic Press, 1969.
  • 9
    Ware JE, Sherbourne CD. A 36-item short-form health survey (SF-36): conceptual framework and item selection. Med Care 1992; 30: 473483.